BioCardia Inc (NAS:BCDA)
$ 2.43 0.05 (2.1%) Market Cap: 8.51 Mil Enterprise Value: 8.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

Q2 2022 BioCardia Inc Earnings Call Transcript

Aug 10, 2022 / 08:30PM GMT
Release Date Price: $22.5 (+1.00%)
Operator

Ladies and gentlemen, thank you for standing by. Good day, and welcome to the BioCardia 2022 second- quarter conference call. (Operator Instructions)

Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately one hour after the end of the call through August 24, 2022.

I would now like to turn the conference over to Jules Abraham of CORE IR, the company's Investor Relations firm. Please go ahead.

Jules Abraham
CORE IR - IR

Thank you, [Kate]. Good afternoon, everyone. And thank you for participating in today's conference call. Joining me from BioCardia's leadership team today are Peter Altman, PhD, President and Chief Executive Officer; and David McClung, the company's Chief Financial Officer.

During this call, management will be making forward-looking statements, including statements that address BioCardia's expectations for future performance or operational

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot